Back
Aurinia Pharmaceuticals Vs. Xenon Pharmaceuticals Industry Stock Comparison
Sell
50
AUPH
Aurinia Pharmaceuticals
Last Price:
5.80
Seasonality Move:
0.65%
Buy
54
XENE
Xenon Pharmaceuticals
Last Price:
39.72
Seasonality Move:
2.06%
Sell
50
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $5.77. The Score for AUPH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Xenon Pharmaceuticals (XENE)
is a Buy
Is Xenon Pharmaceuticals a Buy, Sell or Hold?
- The current Xenon Pharmaceuticals [XENE] share price is $40.34. The Score for XENE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- XENE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $5.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
XENE Stock Price Chart
What is Xenon Pharmaceuticals's stock price today?
-
The Xenon Pharmaceuticals share price today is $40.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XENE is experiencing slight buying pressure.
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 70.09 | Buy |
| Chaikin Money Flow: | 2418307 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.91 - 5.27) | Buy |
| Bollinger Bands (100): | (4.85 - 7.81) | Sell |
XENE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 41.7 | Sell |
| Chaikin Money Flow: | 26925 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.13 - 42.61) | Sell |
| Bollinger Bands (100): | (41.82 - 47.18) | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.22 | Buy |
| 20-day SMA: | 5.12 | Buy |
| 50-day SMA: | 5.11 | Buy |
| 200-day SMA: | 7.46 | Sell |
| 8-day EMA: | 5.29 | Buy |
| 20-day EMA: | 5.18 | Buy |
| 50-day EMA: | 5.4 | Buy |
| 200-day EMA: | 7.08 | Sell |
XENE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.4 | Sell |
| 20-day SMA: | 41.4 | Sell |
| 50-day SMA: | 42.36 | Sell |
| 200-day SMA: | 40.03 | Buy |
| 8-day EMA: | 41.07 | Sell |
| 20-day EMA: | 41.54 | Sell |
| 50-day EMA: | 42.38 | Sell |
| 200-day EMA: | 41.1 | Sell |
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
Xenon Pharmaceuticals Earnings Growth & XENE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.30 per share.
Aurinia Pharmaceuticals Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xenon Pharmaceuticals Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||